[Immunophenotyping in chronic B-cell lymphatic leukemia]

O Kopecký1, J Krejsek, J Voglová

  • 1Oddĕlení klinické imunologie a alergologie FN, Hradec Králové.

Vnitrni Lekarstvi
|March 1, 1994
PubMed

Insights

Immunophenotyping identified characteristic surface molecules in B-cell chronic lymphocytic leukemia (B-CLL) patients. Reduced T cells and NK cells were linked to immunodeficiency in B-CLL.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a common hematological malignancy.
  • Immunophenotyping is crucial for diagnosing and characterizing B-CLL.
  • Patients with B-CLL often exhibit compromised immune function.

Purpose of the Study:

  • To analyze the immunophenotypic profile of B-CLL cells.
  • To investigate the relationship between B-CLL immunophenotype and immune status.

Main Methods:

  • Immunophenotyping analysis was performed on peripheral blood cells.
  • Flow cytometry was used to identify cell surface markers.
  • Data from 67 B-CLL patients were analyzed.

Main Results:

  • B-CLL cells typically express HLA DR, pan B-cell markers, and CD5.
  • Aberrant expression, including the absence of some pan B-cell markers, was observed.
  • A significant reduction in T lymphocytes, their subsets, and NK cells was noted in B-CLL patients.

Conclusions:

  • Immunophenotyping confirms B-CLL diagnosis and reveals aberrant cell surface markers.
  • Reduced T and NK cell populations in B-CLL patients correlate with increased susceptibility to infections due to immunodeficiency.

Related Concept Videos